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Some writers believe that a dictionary is a graveyard for
words, because as soon as a word is defined, it is limited to a
particular meaning and consequently it is ‘effectively dead’.
It may thus be encouraging that the field of functional
genomics is still unable to define itself. Is functional
genomics limited to high-throughput experiments of entire
genomic or proteomic complements, or can it focus on
systems? How do genome comparisons and research on
diagnostics and cures for diseases fit into this field? Does
functional genomics really differ from molecular biology?
The conference ‘Functional Genomics: The Future of
Biology’, which took place at the European Molecular
Biology Laboratory (EMBL) in rainy Heidelberg, gave repre-
sentation to all sides of this nascent field, bringing together
the top researchers from comparative genomics, transcrip-
tome profiling, proteomics, structural biology, systems
biology, and medical research. Speakers came mainly from
academic institutes, but industry was also represented by a
few talks. The talks spanned research in most of the model
organisms:  Escherichia coli,  Saccharomyces cerevisiae,
Caenorhabditis elegans, Drosophila melanogaster, Anopheles
gambiae, mouse and the humble human. Overall, the con-
ference was an exciting and impressive view of the state of
functional genomics today (Figure 1).
Although the range of subjects under the umbrella of func-
tional genomics is wide, some of the properties of ‘global
research’ are becoming clear, showing that the field is matur-
ing. The unifying feature of functional genomics is its high
throughput, or as Ewan Birney (EMBL European Bioinfor-
matics Institute, Hinxton, UK) put it, functional genomics is
“molecular biology in a 96-well format”. More importantly,
though, the familiar theme of integration ran through most of
the talks. Many of the talks described research on the integra-
tion of datasets from high-throughput experiments. The
‘future of biology’, judging from this conference, seems to be
the integration of data from various high-throughput experi-
ments to obtain global views of biological processes.
Rick Young (Whitehead Institute for Biomedical Research,
Cambridge, USA) presented his work on the transcriptional
regulatory circuitry of S. cerevisiae. His group was able to
derive a strain expressing a tagged version of each of 106
transcriptional regulators in yeast. Using a procedure involv-
ing chromatin immunoprecipitation and hybridization to
microarrays, the strains were then used to retrieve all of the
promoter sequences to which these regulators bind from the
whole genome. This information was then used to examine
the circuitry of the regulatory programs, leading to the
detection of several ‘network motifs’, such as autoregulation,
multi-component loops and feedforward loops. When the
promoter-binding data were combined with expression data,
a detailed picture of the yeast cell-cycle transcription regula-
tory network emerged. Young noted that it was the use of
multiple data sources that was key to the insights into the
cell cycle gained from the work. Esti Yeger-Lotem (Hebrew
University, Jerusalem, Israel) described similar work on the
discovery of complex regulatory circuits in S. cerevisiae by
integration of data on the binding of proteins to DNA with
protein-protein interaction data. 
Marc Vidal (Dana-Farber Cancer Institute, Boston, USA)
also spoke of developing hypotheses by integrating func-
tional maps derived from high-throughput datasets, such as
from expression profiling, protein interaction mapping,
protein localization, biochemical genomics, structural
genomics, and knock-out experiments. Vidal placed the
notion of integration in the context of C. elegans, the model
organism with which he mainly works, and gave examples of
processes studied in this way, including vulval development.
Peer Bork (EMBL, Heidelberg, Germany) discussed the inte-
gration of three methods for the discovery of functional asso-
ciations between genes by comparative genomics: two genes
are likely to have related functions if they are found togetherin the genome in several species (gene neighborhood), if
they are both present in one set of species but absent from
another (phylogenetic pattern), or if they are fused in one or
more species (domain fusion). Taking these methods
together has allowed Bork and colleagues to infer the func-
tion of an uncharacterized protein from its associations with
other proteins. Bork also discussed another method, called
anti-correlation, in which two entire protein families are
linked if their presence and absence across genomes are
complementary, in other words if one is always absent where
the other is present and vice versa. 
One of the most exciting aspects of functional genomics is
the breathtaking view of the organism that it makes possible.
Stuart Kim (Stanford University Medical School, USA) pre-
sented a new way to view clustering of genes according to
their expression in many experiments. The display of the
clustering is visually impressive: similarity of expression
profile corresponds to proximity in a two dimensional plane
and the gene density in the plane is shown in the third
dimension. Application of Kim’s algorithm to data on
expression of 98% of C. elegans genes in over 500 experi-
ments revealed a rugged mountain range, and an analysis of
the genes that composed each mountain showed that they
were generally genes known to be involved in the same
biological process, such as the response to heat shock, the
development of the gut or of muscles, and so on. 
The view from proteomics was equally impressive, with the
arrival of protein chips. Michael Snyder (Yale University, New
Haven, USA) presented what he called the ‘yeast proteome
version 1.0’: a protein chip of 5,800 S. cerevisiae proteins
(each fused to glutathione S-transferase-polyhistidine tags),
corresponding to about 93% of the total genes. He described
the various experiments his group has performed using these
chips, including screening for protein-protein interactions,
protein-lipid interactions, interactions between small mole-
cules and proteins, and for post-translational modifications. 
The general structure of a global view of the genome or pro-
teome can itself reveal a major surprise, as shown by Giulio
Superti-Furga (Cellzome AG, Heidelberg, Germany). Superti-
Furga presented the results of his group’s work on determin-
ing protein complexes using tandem-affinity purification and
mass spectrometry. Most interestingly, his results led to the
estimation that 85% of S. cerevisiae proteins form complexes
that are connected in large networks by sharing of members
between different complexes. As many as 40% of the proteins
are a part of more than one complex. Frank Holstege (Uni-
versity Medical Center, Utrecht, The Netherlands) noted that,
from his analysis, Superti-Furga’s data contain the lowest
number of false positives of the large-scale protein-protein
interaction datasets currently available.
Holstege has used co-expression of proteins in microarray
experiments to evaluate the quality of high-throughput
protein-protein interaction results, which are known to
include many false positives. As proteins that are known to
interact do tend to be co-expressed, this seems to be a sensi-
ble screen. Holstege and his group identified several pre-
dicted interactions of products that show high co-expression
and experimentally validated them.
He also showed that although all of the standard methods
for normalization of microarray data assume that the RNA
content of the cell remains constant between experiments,
this is often not the case. Thus, a gene may be reported as
expressed at a lower absolute level in tissue A than in tissue
B, but if (on average) more RNA is present in B, it could
appear after normalization as though the gene is expressed
at higher levels in tissue A. Holstege presented a method for
normalization using an external control that determines
global mRNA changes between experiments.
Sven Bergmann (Weizmann Institute of Science, Rehovot,
Israel) presented a robust ‘signature’ algorithm, developed
by Naama Barkai’s group, which can extract ‘modules’ of
genes with similar expression profiles in all of the available
expression data in S. cerevisiae. The algorithm has the
unique feature of focusing only on the relevant conditions
and is thus applicable to large datasets. Additionally, the
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Figure 1
An illustration of the power of functional genomics, as used in the
publicity for the meeting. The top two ‘experiments’ reveal the same
results, but from the global views below it is clear that the pictures are
different. By analogy, classical molecular biology gives information on only
a single gene while functional genomics gives information on all of the
genes in the organism. Reproduced with permission from Matthias W.
Hentze and Petra Riedinger.modules are context-dependent and thus genes can be
present in more than one module; in this respect the algo-
rithm differs from clustering algorithms that allow each gene
to be in only one cluster. 
Of the talks on structural biology, a particularly interesting
one included a discussion of protein-function prediction
from three-dimensional structure by Janet Thornton (Euro-
pean Bioinformatics Institute). Thornton presented methods
for predicting whether a protein is multimeric, the location
of its active site, and the type of ligand that is bound there, as
well as its biochemical and biological functions. Joel
Sussman (Weizmann Institute of Science) gave convincing
evidence for the existence of unstructured proteins, with a
case study of cholinesterase-like adhesion molecules
(CLAMs). After being unable to crystallize the cytoplasmic
domain of the CLAM gliotactin under many conditions, his
group found that on a two-dimensional scale of mean charge
and hydrophobicity, members of the family are actually pre-
dicted not to fold. Such unstructured proteins are presumed
to assume a structure only when they interact with the
appropriate ‘partner in crime’. Also, Ana Rodrigues (Univer-
sity of York, UK) presented an informatics resource to the
community for making an informed decision regarding
which proteins to select and prioritize for structure determi-
nation, using raw genomic data; this is presently a crucial
issue for structural genomics.
One of the most impressive parts of the field of functional
genomics is systems biology, in which the complex behavior
of a biological process is sought to be understood in terms of
the simpler interactions between genes and their products.
Naama Barkai (Weizmann Institute of Science) showed the
power of mathematical modeling by presenting her group’s
work on searching genetic networks that can explain the pat-
terning of the dorsal region of the Drosophila  embryo. A
model was developed that gave the greatest robustness to
changes in gene dosage; this predicted that diffusion of the
bone morphogenetic protein (BMP)-related ligand Decapen-
taplegic requires the BMP inhibitor Short gastrulation and
the accessory protein Twisted gastrulation, which was veri-
fied experimentally. 
Finally, Stan Leibler of the unusually named Laboratory for
Living Matter (Rockefeller University, New York, USA) pre-
sented his work on natural systems in Drosophila and syn-
thetic networks in E. coli, which have the capacity for some
extremely complicated behavior. He showed that ‘tinkering’
with these circuits by combining five different types of pro-
moters in front of the transcription factors LacI, TetR and
Lambda CI in all 125 possible combinations can produce a
wide range of behaviors.
If the topics described here are the work of a field without a
definition, perhaps we should hope its definition remains
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